• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉粥样硬化中的炎症趋化因子。

Inflammatory Chemokines in Atherosclerosis.

机构信息

Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, 80336 Munich, Germany.

Department of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.

出版信息

Cells. 2021 Jan 25;10(2):226. doi: 10.3390/cells10020226.

DOI:10.3390/cells10020226
PMID:33503867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7911854/
Abstract

Atherosclerosis is a long-term, chronic inflammatory disease of the vessel wall leading to the formation of occlusive or rupture-prone lesions in large arteries. Complications of atherosclerosis can become severe and lead to cardiovascular diseases (CVD) with lethal consequences. During the last three decades, chemokines and their receptors earned great attention in the research of atherosclerosis as they play a key role in development and progression of atherosclerotic lesions. They orchestrate activation, recruitment, and infiltration of immune cells and subsequent phenotypic changes, e.g., increased uptake of oxidized low-density lipoprotein (oxLDL) by macrophages, promoting the development of foam cells, a key feature developing plaques. In addition, chemokines and their receptors maintain homing of adaptive immune cells but also drive pro-atherosclerotic leukocyte responses. Recently, specific targeting, e.g., by applying cell specific knock out models have shed new light on their functions in chronic vascular inflammation. This article reviews recent findings on the role of immunomodulatory chemokines in the development of atherosclerosis and their potential for targeting.

摘要

动脉粥样硬化是一种血管壁的慢性、长期炎症性疾病,可导致大血管中形成闭塞性或易破裂的病变。动脉粥样硬化的并发症可能变得严重,并导致心血管疾病(CVD),造成致命后果。在过去的三十年中,趋化因子及其受体在动脉粥样硬化的研究中引起了广泛关注,因为它们在动脉粥样硬化病变的发展和进展中发挥着关键作用。它们协调免疫细胞的激活、募集和浸润,以及随后的表型变化,例如巨噬细胞对氧化低密度脂蛋白(oxLDL)的摄取增加,促进泡沫细胞的形成,这是形成斑块的一个关键特征。此外,趋化因子及其受体维持适应性免疫细胞的归巢,但也驱动促动脉粥样硬化的白细胞反应。最近,通过应用细胞特异性敲除模型等特定靶向方法,为它们在慢性血管炎症中的作用提供了新的认识。本文综述了免疫调节趋化因子在动脉粥样硬化发展中的作用及其作为靶点的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fb/7911854/18e09d6b3908/cells-10-00226-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fb/7911854/af8a29bd04a4/cells-10-00226-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fb/7911854/18e09d6b3908/cells-10-00226-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fb/7911854/af8a29bd04a4/cells-10-00226-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fb/7911854/18e09d6b3908/cells-10-00226-g002.jpg

相似文献

1
Inflammatory Chemokines in Atherosclerosis.动脉粥样硬化中的炎症趋化因子。
Cells. 2021 Jan 25;10(2):226. doi: 10.3390/cells10020226.
2
Chemokines in atherosclerosis: proceedings resumed.动脉粥样硬化中的趋化因子:会议续会。
Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):742-50. doi: 10.1161/ATVBAHA.113.301655. Epub 2014 Jan 16.
3
Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?趋化因子与动脉粥样硬化斑块进展:迈向治疗靶点?
Curr Pharm Des. 2007;13(10):1039-52. doi: 10.2174/138161207780487584.
4
Atherosclerosis as an inflammatory disease.动脉粥样硬化作为一种炎症性疾病。
Curr Pharm Des. 2012;18(28):4266-88. doi: 10.2174/138161212802481237.
5
Chemokines in the vascular inflammatory response of atherosclerosis.趋化因子在动脉粥样硬化血管炎症反应中的作用。
Cardiovasc Res. 2010 May 1;86(2):192-201. doi: 10.1093/cvr/cvp391. Epub 2009 Dec 9.
6
Elucidating the role of chemokines in inflammaging associated atherosclerotic cardiovascular diseases.阐明趋化因子在与衰老相关的动脉粥样硬化性心血管疾病中的作用。
Mech Ageing Dev. 2024 Aug;220:111944. doi: 10.1016/j.mad.2024.111944. Epub 2024 May 21.
7
P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.P2Y6基因缺陷可限制小鼠的血管炎症和动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2237-45. doi: 10.1161/ATVBAHA.114.303585. Epub 2014 Aug 7.
8
Targeting the chemokine network in atherosclerosis.靶向动脉粥样硬化中的趋化因子网络。
Atherosclerosis. 2021 Aug;330:95-106. doi: 10.1016/j.atherosclerosis.2021.06.912. Epub 2021 Jun 29.
9
Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.抑制Orai1钙库操纵性钙通道可预防泡沫细胞形成和动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):618-28. doi: 10.1161/ATVBAHA.116.307344. Epub 2016 Feb 25.
10
Regulation of atherosclerotic plaque inflammation.动脉粥样硬化斑块炎症的调节。
J Intern Med. 2015 Nov;278(5):462-82. doi: 10.1111/joim.12367.

引用本文的文献

1
Exploration of potential biomarkers and immune cell infiltration characteristics for peripheral atherosclerosis in sjögren's syndrome based on comprehensive bioinformatics analysis and machine learning.基于综合生物信息学分析和机器学习探索干燥综合征外周动脉粥样硬化的潜在生物标志物和免疫细胞浸润特征
Front Genet. 2025 Jul 30;16:1546315. doi: 10.3389/fgene.2025.1546315. eCollection 2025.
2
Interplay of rheumatoid arthritis and cardiovascular disease: Insights and prospects.类风湿性关节炎与心血管疾病的相互作用:见解与展望。
SAGE Open Med. 2025 Jul 23;13:20503121251330171. doi: 10.1177/20503121251330171. eCollection 2025.
3

本文引用的文献

1
CX3CL1 and IL-15 Promote CD8 T cell chemoattraction in HIV and in atherosclerosis.CX3CL1 和 IL-15 促进 HIV 和动脉粥样硬化中的 CD8 T 细胞趋化作用。
PLoS Pathog. 2020 Sep 25;16(9):e1008885. doi: 10.1371/journal.ppat.1008885. eCollection 2020 Sep.
2
Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1-CX3CL1 interaction.人类CD16+单核细胞通过CX3CR1-CX3CL1相互作用促进动脉粥样硬化内皮细胞表型。
Cardiovasc Res. 2021 May 25;117(6):1510-1522. doi: 10.1093/cvr/cvaa234.
3
Increased cardiovascular and atherosclerosis markers in blood of older patients with atopic dermatitis.
High-Content Microscopy Drug Screening Platform for Regulators of the Extracellular Digestion of Lipoprotein Aggregates by Macrophages.
用于巨噬细胞对脂蛋白聚集体细胞外消化调节剂的高内涵显微镜药物筛选平台
ACS Pharmacol Transl Sci. 2025 May 14;8(6):1567-1579. doi: 10.1021/acsptsci.4c00675. eCollection 2025 Jun 13.
4
Role of mitochondria in physiological activities, diseases, and therapy.线粒体在生理活动、疾病及治疗中的作用。
Mol Biomed. 2025 Jun 19;6(1):42. doi: 10.1186/s43556-025-00284-5.
5
Progress in macrophage immune regulation of atherosclerosis.巨噬细胞对动脉粥样硬化免疫调节的研究进展
Am J Transl Res. 2025 May 15;17(5):3261-3275. doi: 10.62347/GMTC2479. eCollection 2025.
6
Age, inflammation, alkaline phosphatase, and coronary artery calcification in firefighters.消防员的年龄、炎症、碱性磷酸酶与冠状动脉钙化
BMC Cardiovasc Disord. 2025 Apr 23;25(1):309. doi: 10.1186/s12872-025-04750-4.
7
The role of immune checkpoints PD-1 and CTLA-4 in cardiovascular complications leading to heart failure.免疫检查点蛋白PD-1和CTLA-4在导致心力衰竭的心血管并发症中的作用。
Front Immunol. 2025 Apr 4;16:1561968. doi: 10.3389/fimmu.2025.1561968. eCollection 2025.
8
Associations and mediators between vitiligo and cardiovascular diseases: a Mendelian randomization study.白癜风与心血管疾病之间的关联及中介因素:一项孟德尔随机化研究。
Sci Rep. 2025 Apr 1;15(1):11110. doi: 10.1038/s41598-025-95638-y.
9
The Role of Neutrophil Extracellular Traps in Atherosclerosis: From the Molecular to the Clinical Level.中性粒细胞胞外诱捕网在动脉粥样硬化中的作用:从分子水平到临床水平
J Inflamm Res. 2025 Mar 26;18:4421-4433. doi: 10.2147/JIR.S507330. eCollection 2025.
10
Inflammatory burden index (IBI) and body roundness index (BRI) in gallstone risk prediction: insights from NHANES 2017-2020.炎症负担指数(IBI)和身体圆润度指数(BRI)在胆结石风险预测中的作用:来自2017 - 2020年美国国家健康与营养检查调查(NHANES)的见解
Lipids Health Dis. 2025 Feb 21;24(1):63. doi: 10.1186/s12944-025-02472-2.
老年特应性皮炎患者血液中心血管和动脉粥样硬化标志物增加。
Ann Allergy Asthma Immunol. 2020 Jan;124(1):70-78. doi: 10.1016/j.anai.2019.10.013. Epub 2019 Oct 14.
4
Neutrophil extracellular traps induced by IL-8 aggravate atherosclerosis via activation NF-κB signaling in macrophages.白细胞介素-8 诱导的中性粒细胞胞外诱捕网通过激活巨噬细胞中的 NF-κB 信号加重动脉粥样硬化。
Cell Cycle. 2019 Nov;18(21):2928-2938. doi: 10.1080/15384101.2019.1662678. Epub 2019 Sep 8.
5
Inhibitory effect of recombinant human CXCL8(3-72)K11R/G31P on atherosclerotic plaques in a mouse model of atherosclerosis.重组人 CXCL8(3-72)K11R/G31P 对动脉粥样硬化小鼠模型中动脉粥样斑块的抑制作用。
Immunopharmacol Immunotoxicol. 2019 Jun;41(3):446-454. doi: 10.1080/08923973.2019.1616753. Epub 2019 May 24.
6
Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study.马拉维若强化治疗对高心血管风险的HIV抑制患者动脉粥样硬化进展的影响。一项随机交叉试点研究。
Open Forum Infect Dis. 2019 Mar 7;6(4):ofz112. doi: 10.1093/ofid/ofz112. eCollection 2019 Apr.
7
CXCL12 Derived From Endothelial Cells Promotes Atherosclerosis to Drive Coronary Artery Disease.源自内皮细胞的CXCL12促进动脉粥样硬化以引发冠状动脉疾病。
Circulation. 2019 Mar 5;139(10):1338-1340. doi: 10.1161/CIRCULATIONAHA.118.037953.
8
Hematopoietic ChemR23 (Chemerin Receptor 23) Fuels Atherosclerosis by Sustaining an M1 Macrophage-Phenotype and Guidance of Plasmacytoid Dendritic Cells to Murine Lesions-Brief Report.造血细胞 Chemerin 受体 23(ChemR23)通过维持 M1 巨噬细胞表型和浆细胞样树突状细胞向小鼠病变部位的趋化作用促进动脉粥样硬化——简短报告。
Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):685-693. doi: 10.1161/ATVBAHA.119.312386.
9
Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation.基于巨噬细胞移动抑制因子(MIF)的动脉粥样硬化和炎症治疗概念。
Thromb Haemost. 2019 Apr;119(4):553-566. doi: 10.1055/s-0039-1677803. Epub 2019 Feb 4.
10
Atypical Chemokine Receptors in Cardiovascular Disease.非典型趋化因子受体在心血管疾病中的作用
Thromb Haemost. 2019 Apr;119(4):534-541. doi: 10.1055/s-0038-1676988. Epub 2019 Feb 4.